BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6504737)

  • 1. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
    Juszczyk J
    Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response].
    Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ
    Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J; Babiuch L; Górska E; Kassur B
    Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
    Kiczka W; Juszczyk J; Adamek J
    Pol Tyg Lek; 1987 Feb; 42(7):192-6. PubMed ID: 3299322
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with thymic extract TFX for chronic active hepatitis B.
    Dworniak D; Tchórzewski H; Pokoca L; Tkacz B; Drobnik S; Baj Z; Luciak M
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):537-47. PubMed ID: 1841551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
    Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of thymic extract on allogeneic MLR and mitogen-induced responses in patients with chronic active hepatitis B.
    Zeman K; Dworniak D; Tchórzewski H; Pokoca L; Majewska E
    Immunol Invest; 1991 Dec; 20(7):545-55. PubMed ID: 1836778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
    Romeo F; Arcoria D; Palmisano L; Polosa P
    Arzneimittelforschung; 1985; 35(8):1317-22. PubMed ID: 3907642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
    Galli M; Crocchiolo P; Negri C; Caredda F; Lazzarin A; Moroni M
    Drugs Exp Clin Res; 1985; 11(9):665-9. PubMed ID: 3916838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic active HBsAg-positive hepatitis with thymostimulin].
    Nardiello S; Russo M; Pizzella T; Galanti B; Giusti G
    G Ital Chemioter; 1984; 31(1-2):181-4. PubMed ID: 6468826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo].
    Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J
    Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term thymosine factor x/TFx/treatment on T lymphocyte subpopulations and peripheral blood mononuclear cell cytotoxicity in chronic active hepatitis B.
    Baj Z; Pokoca L; Tchórzewski H; Dworniak D; Tkacz B
    J Investig Allergol Clin Immunol; 1991 Aug; 1(4):239-46. PubMed ID: 1669583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
    Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W
    Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon treatment in chronic hepatitis B].
    Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia.
    Lever AM; Waters J; Brook MG; Karayiannis P; Thomas HC
    Lancet; 1990 Jun; 335(8704):1529. PubMed ID: 1972457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of thymus extract TFX (Polfa) on hemoglobin level and peripheral blood erythrocyte count].
    Lewandowicz J
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):471-2. PubMed ID: 2277791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of chronic hepatitis B].
    Telegdy L
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.